Phosphorylation sites of HER2/c-erbB-2: role in cell growth and in disease

Rukhshan Khurshid1, Mahjabeen Saleem2, Gul-e-Raana3

  • 1Department of Biochemistry, Fatima Jinnah Medical College, Lahore, Pakistan.

Acta Biochimica Polonica
|November 16, 2014
PubMed

Insights

This study identifies key phosphorylation sites on the HER2/c-erbB-2 protein, crucial for understanding its role in breast cancer development. Findings aid in developing novel therapeutic strategies targeting HER2 signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The protein kinase c-erbB-2 (HER2) is a receptor tyrosine kinase implicated in oncogenesis.
  • HER2 signaling is critical in various cancers, particularly breast cancer.

Purpose of the Study:

  • To predict phosphorylation sites on HER2/c-erbB-2.
  • To elucidate the role of these sites in cancer development and signaling.
  • To identify potential therapeutic targets.

Main Methods:

  • Sequence homology analysis comparing HER2 to other receptor tyrosine kinases.
  • PROSITE database search to identify active and phosphorylation sites.
  • Analysis of phosphorylation within the N-lobe, catalytic loop, and activation loop.

Main Results:

  • Highest sequence homology (77%) found with the epidermal growth factor receptor kinase domain.
  • Identified active sites in the N-lobe (glycine-rich phosphate-binding loop).
  • Confirmed phosphorylation of the catalytic loop (Asp108) and activation loop, crucial for substrate binding and signaling.

Conclusions:

  • The study enhances understanding of HER2 signaling by identifying uncharacterized proteins and phosphorylation events.
  • Phosphorylation of the activation loop is confirmed, providing insights into HER2 function.
  • Findings offer valuable information for designing new therapeutic strategies against HER2-driven cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.3K